Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rashmi Chugh

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Rare Tumors|December 4, 2018
Canonical Wnt/β-catenin signaling activation in soft-tissue sarcomas: A comparative study of synovial sarcoma and leiomyosarcomaLaurence M Briski, Dafydd G Thomas, Rajiv M Patel, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2012
Results of a phase II study of sirolimus and cyclophosphamide in patients with advanced sarcomaScott M Schuetze, Lili Zhao, Rashmi Chugh, et al.
The Oncologist|May 2, 2008
Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumorsHussein Tawbi, Dafydd Thomas, David R Lucas, et al.
BMC Cancer|August 22, 2016
SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapyElizabeth J Davis, Lili Zhao, David R Lucas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 30, 2022
Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204Jessica P Hwang, Kathryn B Arnold, Joseph M Unger, et al.
Sarcoma|April 10, 2019
Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain MetastasesBrittany L Siontis, Lili Zhao, Monika Leja, et al.
American Journal of Clinical Oncology|February 22, 2011
Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremityAaron Sabolch, Mary Feng, Kent Griffith, et al.
JCI Insight|June 17, 2020
Wnt/β-catenin-activated Ewing sarcoma cells promote the angiogenic switchAllegra G Hawkins, Elisabeth A Pedersen, Sydney Treichel, et al.
American Journal of Clinical Oncology|January 13, 2012
Phase II trial of cetuximab in patients with metastatic or locally advanced soft tissue or bone sarcomaHuan T Ha, Kent A Griffith, Mark M Zalupski, et al.
The Oncologist|February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Rare Tumors|December 4, 2018
Canonical Wnt/β-catenin signaling activation in soft-tissue sarcomas: A comparative study of synovial sarcoma and leiomyosarcomaLaurence M Briski, Dafydd G Thomas, Rajiv M Patel, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2012
Results of a phase II study of sirolimus and cyclophosphamide in patients with advanced sarcomaScott M Schuetze, Lili Zhao, Rashmi Chugh, et al.
The Oncologist|May 2, 2008
Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumorsHussein Tawbi, Dafydd Thomas, David R Lucas, et al.
BMC Cancer|August 22, 2016
SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapyElizabeth J Davis, Lili Zhao, David R Lucas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 30, 2022
Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204Jessica P Hwang, Kathryn B Arnold, Joseph M Unger, et al.
Sarcoma|April 10, 2019
Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain MetastasesBrittany L Siontis, Lili Zhao, Monika Leja, et al.
American Journal of Clinical Oncology|February 22, 2011
Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremityAaron Sabolch, Mary Feng, Kent Griffith, et al.
JCI Insight|June 17, 2020
Wnt/β-catenin-activated Ewing sarcoma cells promote the angiogenic switchAllegra G Hawkins, Elisabeth A Pedersen, Sydney Treichel, et al.
American Journal of Clinical Oncology|January 13, 2012
Phase II trial of cetuximab in patients with metastatic or locally advanced soft tissue or bone sarcomaHuan T Ha, Kent A Griffith, Mark M Zalupski, et al.
The Oncologist|February 25, 2012
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003Elizabeth Fox, Shreyaskumar Patel, J Kyle Wathen, et al.
Pageof 13